Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-24-027058
Filing Date
2024-08-16
Accepted
2024-08-16 08:01:30
Documents
1
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3020
  Complete submission text file 0001437749-24-027058.txt   4725
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10220-L OLD COLUMBIA ROAD COLUMBIA MD 21046-2364
Business Address
Tardugno Michael H (Reporting) CIK: 0001384550 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15911 | Film No.: 241214166